At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antihypertensives; Vasodilators
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Beta 1 adrenergic receptor antagonists; Serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 24 Aug 1999 Discontinued-I for Hypertension in United Kingdom (Unknown route)
- 12 May 1997 No-Development-Reported for Hypertension in United Kingdom (Unknown route)